Decode News AI
简体繁體

CVS White Paper Says GLP-1 Drugs Need $350 Monthly Price to Break Even

2026-11-16 22:46 EST · AI-compiled · 242 words · about 1 min · Views …
Photo: AI-generated illustration

LAS VEGAS - CVS Health released a white paper at the HLTH conference on Nov. 15—widely reported on Nov. 16—finding that GLP-1 medications cut hospitalizations by up to 42% but still leave employers paying $3,900 more per patient over three years unless net prices drop to $350 a month.

Medical Savings Trail Prescription Costs Under Current Employer Pricing

Analyzing Aetna insurance claims from 2023 to 2025, CVS found GLP-1 users experienced 34% to 42% lower hospitalization rates and 10% to 12% fewer emergency room visits in years one and two. But they spend $13,300 more on prescriptions, netting out to $3,900 in additional costs per person taking GLP-1s, CVS found," Healthcare Dive reported.

Medicare Pilot Pricing Sparks Call for Drugmaker Discounts

Employers currently pay net prices averaging $617 to $766 monthly, compared with $245 a month charged to Medicare by Eli Lilly and Novo Nordisk in a federal pilot. They're still making money at that. So why are they charging such high prices to employers?" CVS Chief Medical Officer Amy Compton-Phillips told Healthcare Dive.

Sources

Found a factual error or typo? Tell us

Follow Decode News AI on Telegram

Live updates: every new story is pushed the moment it publishes — dozens a day, no digest delay.

@decodenewsai · Subscribe now

Free · unsubscribe anytime

Comments